Published in AMIA Annu Symp Proc on January 01, 2003
Exploring the ability of natural language processing to extract data from nursing narratives. Comput Inform Nurs (2009) 1.30
Managing the life cycle of electronic clinical documents. J Am Med Inform Assoc (2006) 1.15
Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA (1995) 26.38
Adverse drug reactions: definitions, diagnosis, and management. Lancet (2000) 16.12
Computerized surveillance of adverse drug events in hospital patients. JAMA (1991) 8.21
The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv (1995) 6.73
Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc (1998) 6.21
Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med (1993) 4.40
Direct text entry in electronic progress notes. An evaluation of input errors. Methods Inf Med (2003) 4.00
Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol (1998) 2.32
Computerized surveillance of adverse drug reactions in hospital: implementation. Eur J Clin Pharmacol (1999) 1.24
Adverse drug reactions: who is to know? BMJ (1993) 1.13
Multidisciplinary adverse drug reaction surveillance program. Am J Hosp Pharm (1990) 1.10
Academic detailing improves identification and reporting of adverse drug events. Pharm World Sci (1999) 1.03
Medication error reporting: a survey of nursing staff. J Nurs Care Qual (2000) 0.93
Estimating the rate of adverse drug reactions with capture-recapture analysis. Am J Health Syst Pharm (1996) 0.84
Adverse drug event reporting at Veterans Affairs facilities. Am J Health Syst Pharm (1996) 0.80
High rates of adverse drug events in a highly computerized hospital. Arch Intern Med (2005) 4.68
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs? J Clin Oncol (2009) 2.16
The Research on Adverse Drug Events and Reports (RADAR) project. JAMA (2005) 2.08
Overestimation of the effects of adherence on outcomes: a case study in healthy user bias and hypertension. Heart (2011) 1.68
Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project. J Clin Oncol (2003) 1.50
Critical issues in an electronic documentation system. AMIA Annu Symp Proc (2007) 1.42
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Arch Intern Med (2007) 1.34
Risk factors for adverse drug events: a 10-year analysis. Ann Pharmacother (2005) 1.30
Medication reconciliation: barriers and facilitators from the perspectives of resident physicians and pharmacists. J Hosp Med (2011) 1.28
Effect of admission medication reconciliation on adverse drug events from admission medication changes. Arch Intern Med (2011) 1.20
Behavior ratings of executive function among preschoolers with ADHD. Clin Neuropsychol (2007) 1.18
Pharmacist- versus physician-initiated admission medication reconciliation: impact on adverse drug events. Am J Geriatr Pharmacother (2012) 1.09
Laminin-411 is a vascular ligand for MCAM and facilitates TH17 cell entry into the CNS. PLoS One (2012) 1.07
Designing climate-smart conservation: guidance and case studies. Conserv Biol (2010) 1.03
Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review. Am J Health Syst Pharm (2007) 1.00
Construct validity of the auditory continuous performance test for preschoolers. Dev Neuropsychol (2005) 0.97
Clinicians' perceptions about use of computerized protocols: a multicenter study. Int J Med Inform (2007) 0.94
Development of trigger tools for surveillance of adverse events in ambulatory surgery. Qual Saf Health Care (2010) 0.90
Initial Steps toward Validating and Measuring the Quality of Computerized Provider Documentation. AMIA Annu Symp Proc (2010) 0.88
The orderly and effective visit: impact of the electronic health record on modes of cognitive control. AMIA Annu Symp Proc (2012) 0.88
Rethinking the discharge summary: a focus on handoff communication. Acad Med (2014) 0.87
Crossing the quality chasm: the role of information technology departments. Am J Med Qual (2006) 0.87
Selective and brain-permeable polo-like kinase-2 (Plk-2) inhibitors that reduce α-synuclein phosphorylation in rat brain. ChemMedChem (2013) 0.87
Cognitive analysis of a medication reconciliation tool: applying laboratory and naturalistic approaches to system evaluation. Stud Health Technol Inform (2011) 0.86
Informatics tools for the development of action-oriented triggers for outpatient adverse drug events. AMIA Annu Symp Proc (2008) 0.85
Comparing adherence to two different HIV antiretroviral regimens: an instrumental variable analysis. AIDS Behav (2013) 0.85
Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis. Gut (2006) 0.84
Mapping clinicians' perceptions about computerized protocol use to an IT implementation framework. Stud Health Technol Inform (2007) 0.84
Characterizing "information transfer" by using a Joint Cognitive Systems model to improve continuity of care in the aged. Int J Med Inform (2012) 0.83
Predictive value of alert triggers for identification of developing adverse drug events. J Patient Saf (2009) 0.82
Cognitive evaluation of the predictors of use of computerized protocols by clinicians. AMIA Annu Symp Proc (2003) 0.80
These are the technologies that try men's souls: common-sense health information technology. Pediatrics (2005) 0.80
Consensus building for development of outpatient adverse drug event triggers. J Patient Saf (2011) 0.77
Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors. Bioorg Med Chem Lett (2013) 0.77
Factors associated with screening or treatment initiation among male United States veterans at risk for osteoporosis fracture. Bone (2012) 0.76
Reducing adverse drug events in the outpatient chemotherapy setting: attention must be paid. Cancer (2005) 0.75
In Reply to Sampson et al. Acad Med (2017) 0.75
(1R,2S)-4-(2-cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production. Bioorg Med Chem Lett (2007) 0.75
Pedobarographic and musculoskeletal examination of collegiate dancers in relevé. Foot Ankle Int (2002) 0.75
Out-of-pocket pharmacy expenditures for veterans under medicare part D. Med Care (2007) 0.75
"It Feels Like a Lot of Extra Work": Resident Attitudes About Quality Improvement and Implications for an Effective Learning Health Care System. Acad Med (2017) 0.75
Nurse's role in tracking adverse drug events: the impact of provider order entry. Nurs Adm Q (2005) 0.75
Usability of telehealth technologies. Int J Telemed Appl (2013) 0.75
Reliability in Measuring Preinjury Physical Function in Orthopaedic Trauma. J Orthop Trauma (2015) 0.75
Senior friendly health services. Perspectives (2006) 0.75